Quality Assurance Engineer, Drug Substance Manufacturing

Why Fujifilm is investing US$18m in Arizona chip production. October 16, 2026 Fujifilm is expanding its materials production in Arizona's semiconductor hub, where advanced chipmaking has driven investments totalling $US319bn Fujifilm is investing US$18m to expand production at its facility in Mesa, Arizona, where the company manufactures critical materials for semiconductor production. The investment will support capacity expansion at the plant, which produces chemical mechanical planarisation (CMP) slurries. The company says it also intends to establish new production capabilities to diversify its offering of semiconductor products. Fujifilm expects operations at the extended site to begin in 2027. "As global semiconductor demand continues to increase, demand for CMP slurries - an essential material used in advanced semiconductor manufacturing - is also growing," says Brian O'Donnelly, President and CEO of Fujifilm Electronic Materials. Fujifilm is pursuing this market by investing in its Arizona operations, anchoring its production to a hub of major semiconductor investment. The investment at a glance: * Fujifilm is investing US$18m into its CMP slurry production in Mesa, Arizona. * The company expects production to begin in 2027. * The planned site will support CMP slurry production to cover each stage of chip manufacturing. * The site is intended to bridge Fujifilm's global CMP slurry R&D centre with its production facilities. * The site will support the development of slurries for logic, memory and packaged chips. The CMP slurry market is growing. As semiconductor production scales, the production of materials to support the chip manufacturing process must grow with it. "The advanced semiconductor market has entered a period of significant growth, driven by the rapid expansion of demand related to artificial intelligence," Brian says. CMP slurries are polishing materials used to flatten semiconductor wafer surfaces during the chipmaking process. Smooth, flat wafers are essential to increase precision as chips grow smaller and more complex. In accord with the expansion of semiconductor operations, McKinsey identifies a domestic US supply gap for materials and chemicals to support scaled production. The firm identifies CMP slurry among the materials experiencing significant demand. Fujifilm holds a leading global market share in copper interconnect CMP slurry, which is particularly valuable for its application across logic and memory chips used in AI infrastructure. The company's US$18m production expansion is designed to capture both established and emerging demand. In addition, Fujifilm will add flexible production lines to manufacture materials used across additional processes, supporting the growth of packaged chips. Why Fujifilm is investing in Arizona. Arizona has become one of the most critical locations in US semiconductor manufacturing, home to more than 70 years of semiconductor design, development and production activity, beginning with Motorola in the 1940s. Since 2020, the Arizona Commerce Authority (ACA) has recorded more than US$319bn in semiconductor investment across the state, including 60 plant expansions. Significant developments include a US$100bn investment from TSMC in 2025, establishing three further fabs, two advanced packaging facilities and a major R&D centre. Intel's largest site is also located in Arizona, and the company has invested US$34.5bn into its operations in the state. The state employs more than 181,900 manufacturing workers, the ACA reports, providing the industrial workforce required to support a complex manufacturing hub. Fujifilm also runs its own global R&D centre for CMP slurries at its Mesa site. By adding production capacity nearby, the company intends to accelerate development for new materials to expand its pipeline. With a dense and well-funded concentrated network of fabs, R&D and skilled labour, Arizona's semiconductor ecosystem is a strategic location for Fujifilm to funnel investment. Fujifilm's growth strategy. The Mesa project sits within a wider growth programme for Fujifilm's semiconductor materials business. In February 2026, the company reported a 29.3% year on year revenue rise for the previous fiscal year. Fujifilm is targeting ¥500bn (US$3.17bn) in semiconductor materials sales by 2030. To support this initiative, it is allocating at least ¥100bn (US$630m) to semiconductor R&D investment from 2025 to 2026. Its portfolio extends beyond CMP slurries to serve different stages of chip production, pursuing growth through its "one-stop solution" approach. Beyond the Mesa expansion's introduction of new lines, the company acquired Entegris' process chemicals business for US$700m in 2023. Its global strategy has seen expansions in India, where a semiconductor ecosystem is growing. In June 2026 it signed a Memorandum on Understanding to assess expansions in Dholera. Fujifilm's 2025 Integrated Report outlines its ambition of becoming the world's most trusted semiconductor materials manufacturer. Key companies. Intel: Intel is a US semiconductor manufacturer headquartered in Santa Clara, California, producing processors and other semiconductor products. Fujifilm Electronic Materials supplies materials to Intel's semiconductor supply chain. The companies describe their relationship as collaborative, with Fujifilm providing high-quality products through regional sourcing and supporting supply chain continuity. Samsung Electronics: Samsung Electronics is a South Korean electronics and semiconductor manufacturer. Fujifilm supplies Samsung with a broad portfolio of semiconductor materials and operates manufacturing facilities in Cheonan and Pyeongtaek, South Korea, to support local supply and customer service. Rapidus: Rapidus is a Japanese semiconductor company established in 2022 to develop and manufacture leading-edge logic semiconductors. In February 2026, Fujifilm completed a ¥5bn (US$31.6m) investment in Rapidus. The companies are working together on next-generation semiconductor process development, with Fujifilm supplying semiconductor materials and technologies to support Rapidus' development and manufacturing activities in Japan. Company Portals

Fujifilm India funds an AI endoscopy study at AIIMS Delhi. The CSR-backed trial will test whether AI assistance helps clinicians spot upper gastrointestinal cancers earlier in routine exams. Published: October 15, 2026 Fujifilm India has partnered with the All India Institute of Medical Sciences in New Delhi on a clinical research study into AI-assisted endoscopy for upper gastrointestinal cancers. The work, funded through Fujifilm India's corporate social responsibility program, will evaluate whether AI can help clinicians detect malignancies earlier and more effectively during routine endoscopic exams. Early-stage gastrointestinal lesions are easy to miss. Their appearance is subtle and detection varies between examiners, so missed or delayed diagnoses are common. AI-assisted endoscopy aims to flag suspicious abnormalities in real time, giving the endoscopist a second set of eyes during the procedure rather than after it. The collaboration is intended to generate clinical evidence on whether the approach holds up in Indian patient populations, where upper gastrointestinal cancers remain a heavy burden. The announcement comes as India's health system increasingly tests AI tools in real clinical settings, from imaging to diagnostics to workflow automation.

35 Fujifilm group products win the GOOD DESIGN AWARD 2026. FUJIFILM Corporation achieves the highest number of award-winning products for the eighth consecutive year TOKYO, October 15, 2026 - FUJIFILM Holdings Corporation is pleased to announce that 35 products from across the Fujifilm group including FUJIFILM Corporation and FUJIFILM Business Innovation Corp. have been recognized at the GOOD DESIGN AWARD 2026[*], an esteemed award program organized by the Japan Institute of Design Promotion. The award-winning products span a wide range of business fields, including mirrorless digital cameras, instant cameras in the instax(TM) series, medical equipment, and production color printers. Among the award recipients, FUJIFILM Corporation received the highest number of awards, with 30 products recognized, marking its eighth consecutive year as the top award winner. In developing a wide range of products and services, Fujifilm has pursued high levels of functionality and performance, while also emphasizing design that enhances and fully leverages these strength. This year, 23 products received the iF Design Award and a record-high number of 34 products received the Red Dot Design Award. In the IDEA, 2 products received the "Bronze" award. Fujifilm has been recognized with the Good Design Award for 44 consecutive years since 1983. These achievements demonstrate high recognition for design excellence of Fujifilm products globally. Fujifilm remain committed to developing new value of products and services by not only visually appealing but also realizing designs that emphasize the function of each product and service, thereby creating new value through designs. * [*] The Good Design Award is Japan's only comprehensive design evaluation and promotion program launched by the Japan Industrial Design Promotion Organization (today's Japan Institute of Design Promotion) in 1988, based on the Good Design Selection System (G Mark System) established by the Ministry of International Trade and Industry (today's Ministry of Economy, Trade and Industry) in 1957. GOOD DESIGN AWARD 2026 winners. Excluding unreleased products and products that are only available in limited regions. Interchangeable lens for the X Series of mirrorless digital cameras "FUJINON Lens XC13-33mmF3.5-6.3 OIS" Interchangeable lens for the GFX Series of mirrorless digital cameras "FUJINON Lens GF19-35mmT3.5 PZ OIS WR" Broadcast Zoom lens "FUJINON UA30x7.3BERD" Broadcast Zoom lens "FUJINON UA16x4BERD" * [*] Scheduled for release in Spring 2027 Electronic viewfinder "EVF-GFXC2" * [*] Scheduled for release during 2026 Medical record management solutions "yahgee optional feature: AI support for generating discharge summaries" * * instax, instax Pal 2, instax mini Evo Cinema, instax mini 13, instax mini 99, instax WIDE 400, instax SQUARE 2, instax Link WIDE 2, instax mini Link+ and QuickSnap is registered trademarks or trademarks of FUJIFILM Corporation. * * Revoria Press is a registered trademark or trademark of FUJIFILM Business Innovation Corp. Contact. FUJIFILM Holdings Corporation Design Strategy Office * * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice. * * This news release is issued by FUJIFILM Holdings Corporation in Japan. Fujifilm makes no representation that products on this news release are commercially available in all countries and regions including the US and EU. Approved uses of healthcare products vary by country and region.